{"id":4616,"date":"2025-12-17T14:36:31","date_gmt":"2025-12-17T07:36:31","guid":{"rendered":"https:\/\/www2.si.mahidol.ac.th\/department\/biochemistry\/?p=4616"},"modified":"2025-12-17T14:37:29","modified_gmt":"2025-12-17T07:37:29","slug":"disproportionately-increasing-incidence-of-inflammatory-bowel-disease-in-female-patients-and-the-elderly-an-update-analysis-from-the-global-burden-of-disease-study-2021","status":"publish","type":"post","link":"https:\/\/www2.si.mahidol.ac.th\/department\/biochemistry\/en\/disproportionately-increasing-incidence-of-inflammatory-bowel-disease-in-female-patients-and-the-elderly-an-update-analysis-from-the-global-burden-of-disease-study-2021\/","title":{"rendered":"Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Female Patients and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021"},"content":{"rendered":"
Introduction: To update the global burden of inflammatory bowel disease (IBD) using data from the Global Burden of Disease 2021.<\/p>\n
Methods: Data from Global Burden of Disease 2021 were analyzed to assess the IBD burden.<\/p>\n
Results: In 2021, there were 375,140 new cases and 3.83 million total cases of IBD. Elderly onset IBD accounted for 11% of incidences. 167 countries increased IBD incidence rate, with rates rising in female patients (APC: +0.06%) and the elderly (APC: +0.14%) but stable in male patients and the overall population.<\/p>\n
Discussion: Although the global burden of IBD has decreased overall, it has increased in female patients and the elderly.<\/p>\n